Yarrow Bioscience, Inc. (YARW)
38.03
-1.22
(-3.11%)
USD |
NASDAQ |
Aug 26, 16:00
38.03
0.00 (0.00%)
After-Hours: 16:14
Yarrow Bioscience Max Drawdown (5Y) : 99.92% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 99.92% |
| June 30, 2026 | 99.92% |
| May 31, 2026 | 99.92% |
| April 30, 2026 | 99.92% |
| March 31, 2026 | 99.92% |
| February 28, 2026 | 99.92% |
| January 31, 2026 | 99.92% |
| December 31, 2025 | 99.92% |
| November 30, 2025 | 99.92% |
| October 31, 2025 | 99.92% |
| September 30, 2025 | 99.92% |
| August 31, 2025 | 99.92% |
| July 31, 2025 | 99.92% |
| June 30, 2025 | 99.92% |
| May 31, 2025 | 99.92% |
| April 30, 2025 | 99.92% |
| March 31, 2025 | 99.92% |
| February 28, 2025 | 99.92% |
| January 31, 2025 | 99.92% |
| December 31, 2024 | 99.92% |
| November 30, 2024 | 99.92% |
| October 31, 2024 | 99.92% |
| September 30, 2024 | 99.92% |
| August 31, 2024 | 99.92% |
| July 31, 2024 | 99.92% |
| Date | Value |
|---|---|
| June 30, 2024 | 99.92% |
| May 31, 2024 | 99.92% |
| April 30, 2024 | 99.92% |
| March 31, 2024 | 99.92% |
| February 29, 2024 | 99.92% |
| January 31, 2024 | 99.92% |
| December 31, 2023 | 99.92% |
| November 30, 2023 | 99.92% |
| October 31, 2023 | 99.92% |
| September 30, 2023 | 99.92% |
| August 31, 2023 | 99.92% |
| July 31, 2023 | 99.92% |
| June 30, 2023 | 99.92% |
| May 31, 2023 | 99.92% |
| April 30, 2023 | 99.92% |
| March 31, 2023 | 99.92% |
| February 28, 2023 | 99.92% |
| January 31, 2023 | 99.92% |
| December 31, 2022 | 99.92% |
| November 30, 2022 | 99.85% |
| October 31, 2022 | 99.85% |
| September 30, 2022 | 99.85% |
| August 31, 2022 | 99.81% |
| July 31, 2022 | 99.75% |
| June 30, 2022 | 99.75% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Oramed Pharmaceuticals, Inc. | 94.25% |
| NRX Pharmaceuticals, Inc. | 99.82% |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
| Veru, Inc. | 99.12% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -73.32 |
| Beta (5Y) | 1.933 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 113.3% |
| Historical Sharpe Ratio (5Y) | -0.4904 |
| Historical Sortino (5Y) | -1.011 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.11% |